Patents by Inventor Christopher Belyea

Christopher Belyea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of growth hormone receptor expression and insulin-like growth factor expression
    Patent number: 8637484
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: January 28, 2014
    Assignees: Isis Pharmaceuticals, Inc., Antisense Therapeutics Ltd.
    Inventors: George Tachas, Kenneth Dobie, Ravi Jain, Christopher Belyea, Mark Heffernan
  • Modulation of growth hormone receptor expression and insulin-like growth factor expression
    Patent number: 8623836
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: January 7, 2014
    Assignees: Isis Pharmaceuticals, Inc., Antisense Therapeutics Ltd.
    Inventors: George Tachas, Kenneth Dobie, Ravi Jain, Christopher Belyea, Mark Heffernan
  • MODULATION OF GROWTH HORMONE RECEPTOR EXPRESSION AND INSULIN-LIKE GROWTH FACTOR EXPRESSION
    Publication number: 20110092572
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Application
    Filed: November 23, 2010
    Publication date: April 21, 2011
    Applicants: Antisense Therapeutics Limited, Isis Pharmaceuticals, Inc.
    Inventors: George Tachas, Kenneth W. Dobie, Ravi Jain, Christopher Belyea, Mark Heffernan
  • Modulation of growth hormone receptor expression and insulin-like growth factor expression
    Publication number: 20060178325
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Application
    Filed: February 27, 2004
    Publication date: August 10, 2006
    Inventors: George Tachas, Kenneth Dobie, Christopher Belyea, Mark Heffernan, Ravi Jain
  • Modulation of growth hormone receptor expression and insulin-like growth factor expression
    Publication number: 20050282761
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Application
    Filed: August 25, 2004
    Publication date: December 22, 2005
    Inventors: George Tachas, Kenneth Dobie, Ravi Jain, Christopher Belyea, Mark Heffernan
  • Method for control of depression using c terminal growth hormone (gh) fragment
    Publication number: 20050197286
    Abstract: This invention relates to the prevention and treatment of depression and similar mood disorders in mammals, especially humans. In particular, the invention relates to methods for elevating mood in a mammal, comprising administering to the mammal a therapeutically effective amount of a C terminal growth hormone fragment.
    Type: Application
    Filed: May 2, 2003
    Publication date: September 8, 2005
    Inventors: Gary Wittert, Christopher Belyea
  • Modulation of growth hormone receptor expression and insulin-like growth factor expression
    Publication number: 20040253723
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Application
    Filed: February 26, 2004
    Publication date: December 16, 2004
    Applicant: Isis Pharmaceuticals, Inc.
    Inventors: George Tachas, Kenneth W. Dobie, Ravi Jain, Christopher Belyea, Mark A. Heffernan